MINNEAPOLIS, March 06, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Leerink Partners Global Biopharma Conference 2024 to be held in Miami on March 11-13, 2024. Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, is scheduled for a podium presentation at 8:40 a.m. ET on Wednesday, March 13, 2024. A live webcast of the event will be available using ...